Ok, I partly agree with you on this one, it isn't Eti Maden's main biz, but ABR are not looking at the entirety of their production into specialties, more so the bulk of phase one. Also, your point that ABR is focusing on specialties is contrary to your argument then about ABR's competitive positioning vs Eti Maden and Rio, is it not?
It's also not true for you to claim that no other producers do it. I'll point out that Albermarle became a predominately lithium specialty product producer and that has done it wonders. Smashed earnings estimates in Q1, interestingly Q2 is out tomorrow. So a shift to predominately specialty products has been done before, and done so successfully. Yes it's lithium not borates but the point still stands.
ABR Price at posting:
$1.42 Sentiment: Buy Disclosure: Held
